Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Postpartum Hemorrhage

• Comparing Tranexamic Acid Versus Ecbolics in Preventing Hemorrhage During and After Cesarean Section
• Postpartum Hemorrhage Reduction With Oral Tranexamic Acid: a Clinical Trial
• A Study to Evaluate the Effect of Carbetocin on the QT/QTc Interval in Healthy Subjects
• Tranexamic Acid for the Prevention of Postpartum Hemorrhage in Pregnant Women With Placenta Previa
• Prophylactic Methylergonovine for Twin Cesarean
• Tranexamic Acid in Patients for Caesarian Delivery.
• Intramuscular or Intravenous Tranexamic Acid for the Prevention of Heavy Bleeding After Childbirth in Women at Increased Risk
• In Vitro Evaluation of Spontaneous and Oxytocin-induced Contractility of Pregnant Human Myometrium During Exposure to Dexmedetomidine
• Oxytocin PK/PD in Elective Cesarean Delivery
• Carbetocin Versus Oxytocin for Prophylaxis Against Atonic Primary Post-partum Hemorrhage
• Efficacy of Four Different Treatment Regimes on Postpartum Hemorrhage: A Multicentric Randomized Controlled Trial
• Use of Tranexamic Acid After Vaginal Delivery With Episiotomy a RCT Placebo Control Trail
• The Prophylactic Role of Tranexamic Acid in High Risk Pregnant Women Undergoing Elective Cesarean Section in Prevention of Postpartum Hemorrhage
• Prophylactic Tranexamic Acid Use After Vaginal Delivery
• Prevention of Postpartum Hemorrhage With Tranexamic Acid (Phase 3)
• Oxytocin Maintenance Infusion in Labouring Women Undergoing Cesarean Delivery: an Up-down Sequential Allocation Study
• Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage
• Carbetocin Versus Syntocinon for Prevention of Postpartum Hemorrhage in Cardiac Patients Undergoing Caesarean Section
• Randomization of Oxytocin, Oxytocin+Intrauterine Misoprostol and Carbetosin During C-section
• A Trial of Sublingual Misoprostol to Reduce Primary Postpartum Haemorrhage After Vaginal Delivery
• Oxytocin Versus, Sublingual Misoprostol in the Secondary Prevention of Postpartum Hemorrhage After Vaginal Delivery
• Topical Tranexamic Acid for the Prevention of Postpartum Hemorrhage in Women With Twin Pregnancy
• Topical Tranexamic Acid for the Prevention of Postpartum Hemorrhage in Women Undergoing Elective Cesarean Section
• Calcium Chloride for Prevention of Blood Loss During Intrapartum Cesarean Delivery
• Maintenance Infusion of Oxytocin Following Elective Cesarean Deliveries
• Oxytocin vs Carbetocin at Cesarean Delivery in Women With Morbid Obesity
• Cervical Traction vs. Active Management of 3rd Stage of Labor
• The Efficacy of Tranexamic Acid in Preventing Postpartum Haemorrhage After Caesarean Section
• Prevention of Primary Postpartum Haemorrhage
• Tranexamic Acid for the Prevention of Postpartum Haemorrhage
• Single Dose Intravenous Iron Isomaltoside in Combination With Oral Iron vs Oral Iron Monotherapy in Patients With Anemia After Postpartum Haemorrhage
• Prevention of Postpartum Haemorrhage
• Tranexamic Acid in the Prevention of Postpartum Hemorrhage in Elective Caesarean Section
• Amr Maneuver for Prevention of Postpartum Hemorrhage
• Prevent Postpartum Hemorrhage in Women With Von Willebrand Disease: The VWD-WOMAN Trial
• TRAnexamic Acid for Preventing Blood Loss Following a Cesarean Delivery in Women With Placenta pREVIA
• Carbetocin Versus Ergometrin in the Prevention of Postpartum Hemorrhage
• Tranexamic Acid for the Prevention of Blood Loss in High Risk Delivered Women
• EMG for Uterotonic Efficiency Estimation
• Carbetocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With Twin Pregnancy.
• Tranexamic Acid Versus Sublingual Misoprostol in Reducing Blood Loss During Elective CS in High Risk Cases
• Carbetocin Versus Oxytocin for Prevention of Postcesarean Hemorrhage in Pregnancy With High Risk for PPH
• Misoprostol in the Prevention of Postpartum Haemorrhage
• Oxytocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With Twin Pregnancy
• Oxytocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With BMI ≥ 40kg/m2
• Carbetocin Versus Oxytocin Plus Sublingual Misoprostol in the Management of Atonic Postpartum Hemorrhage
• Oral Tranexamic Acid Plus Sublingual Misoprostol in Atonic Postpartum Hemorrhage
• Tranexamic Acid for Prevention of Hemorrhage in Cesarean Delivery
• Spontaneous and Oxytocin-induced Contractility After Exposure to Intravenous Anesthetic Agents: an In-vitro Study in Human Myometrium
• IV Ketorolac on Platelet Function Post-Cesarean Delivery
• Patient Blood Management for Massive Obstetric Hemorrhage
• Oxytocin and Tranexamic Acid in Pregnant Women With Twin Pregnancy Undergoing Cesarean Section
• Buccal Misoprostol and Intravenous Tranexamic Acid During Emergent Cesarean Delivery
• Sublingual Misoprostol and Tranexamic Acid in Pregnant Women With Twin Pregnancy Undergoing Cesarean Section
• Carbetocin Versus Oxytocin for the Prevention of Postpartum Hemorrhage in Emergency Caesarean Delivery
• Intrauterine Misoprostol Versus Rectal Misoprostol in Reducing Blood Loss During Cesarean Section
• Carbetocin Versus Buccal Misoprostol Plus IV Tranexamic Acid for Prevention of Postpartum Hemorrhage at Cesarean Section
• Carbetocin Versus Oral Tranexamic Acid Plus, Buccal Misoprostol on Blood Loss After Vaginal Delivery
• Carbetocin Versus Syntometrine in Obese Women Undergoing Elective Cesarean
• Buccal Misoprostol Versus IV Oxytocin in Prevention of Postpartum Hemorrhage
• Carbetocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With BMI ≥ 40kg/m2
• Oxytocin i.m./i.v. Versus Carbetocin i.v. in Elective Cesarean Sections
• Preoperative and Postoperative Sublingual Misoprostol for Prevention of Postpartum Blood Loss in Cesarean Section
• Bilateral Uterine Artery Ligation in Reducing Incidence of Postpartum Hemorrhage in Cesarean Section
• Second-Line Uterotonics in Postpartum Hemorrhage: A Randomized Clinical Trial
• Carbetocin Versus Oxytocin and Ergometrine for the Prevention of Postpartum Hemorrhage
• Tranexamic Acid for Prevention of Postpartum Haemorrhage: a Dose-finding Study
• CARBETOCIN VERSUS RECTAL MISOPROSTOL FOR MANAGEMENT OF THIRD STAGE OF LABOR IN WOMEN AT LOW RISK OF POSTPARTUM HEMORRHAGE
• Antibiotics During Intrauterine Balloon Tamponade Placement
• Efficacy of Tranexamic Acid in Preventing Postpartum Haemorrhage After Elective Caesarean Section
• Misoprostol Before and After Cesarean Section
• In Vitro Optimization of Oxytocin-induced Myometrial Contractility by Propranolol
• TRAnexamic Acid for Preventing Postpartum Hemorrhage Following a Cesarean Delivery
• The Relaxant Effect of Nitroglycerin on Oxytocin Desensitized Human Myometrium
• Intraumbilical Oxytocin Versus Placental Cord Drainage in the Management of 3rd Stage of Labor
• Tranexamic Acid in Preventing Postpartum Hemorrhage in High Risk Pregnancies During Elective Cesarean Section
• Oxytocin Administration During Cesarean Section
• Prevention of Postpartum Hemorrhage With TXA
• Intravenous Versus Intramuscular Administration of Methylergonovine for Uterine Contraction in Cesarean Sections
• Prevention of Postpartum Hemorrhage With Tranexamic Acid
• Saving Lives at Birth in Uganda: Building and Sustaining Capacity of Frontline Health Workers - A Program Evaluation
• Ideal Time of Oxytocin Infusion During Cesarean Section
• Carbetocin vs. Oxytocin at Elective Cesarean Section
• Intrauterine Misoprostol Versus Intravenous Oxytocin Infusion During Cesarean Delivery
• Sublingual Misoprostol to Reduce Blood Loss During Elective Cesarean Delivery
• Use of TXA to Prevent Postpartum Hemorrhage
• Prophylactic Oxytocin Before Versus After Placental Delivery to Reduce Blood Loss in Vaginal Delivery
• Comparison of Inhaled Oxytocin (IH) With Intramuscular (IM) Oxytocin in Pregnant Women and With Intravenous (IV) Oxytocin in Healthy Non-pregnant Women
• Effect of Misoprostol in Reducing Post Partum Hemorrhage After Labor Induction by Oxytocin
• IV Versus IM Administration of Oxytocin for Postpartum Bleeding
• Tranexamic Acid for Preventing Postpartum Hemorrhage After Cesarean Section
• Compare Efficacy of Oxytocin Administrations on Postpartum Uterine Contractility
• Early Usage of Bakri Ballon in Managing Postpartum Hemorrhage
• Misoprostol as First Aid Measure to Address Excessive Postpartum Bleeding
• Perioperative Administration of Tranexamic Acid for Placenta Previa and Accreta Study
• Effectiveness of Tranexamic Acid When Used as an Adjunct to Misoprostol for the Treatment of Postpartum Hemorrhage
• Misoprostol+Oxytocin vs. Carbetocin in CS
• Role of Tranexamic Acid Versus Uterine Cooling at Caesarean Section
• Clinical Study to Assess the Equivalence of Tranexamic Acid vs Oxytocin in Reducing the PPH
• Recovery of Oxytocin Responsiveness in Pregnant Human Myometrial Explants After Oxytocin-Induced Desensitization: an In-vitro Analysis of Oxytocin Receptor Expression and Signaling
• Role Of Different Prophylactic Doses Of Intravenous Tranexamic Acid In Reducing Blood Loss At Caesarean Section
• Two Different Regimens of Misoprostol in Retained Placenta
• Prophylactic Use of Intraumbilical Vein Oxytocin Injection in The Management of Third Stage of Labor
• The Effect of Tranexamic Acid on Uterine Blood Flow After Vaginal Delivery
• Effect of Magnesium Sulphate Pre-exposure on Oxytocin-induced Contractility in Desensitized Human Myometrium - an in Vitro Study
• Tranexamic Acid and Ethamsylate For Preventing PPH in Patient Undergoing LSCS at High Risk For PPH
• Uterotonics Using to Reduce Bleeding at Cesarean Section
• Safety, Tolerability and Pharmacokinetics (PK) Study of Oxytocin (GR121619) Administered Via an Inhaled Route in Healthy Female Volunteers
• A Program to Evaluate Riastap® and FIBTEM® for the Early Control and Treatment of Postpartum Hemorrhage (PERFECT PPH)
• Could Pre-operative Rectal Misoprostol Reduce Intra-operative Blood Loss During Ceserean Section?
• Clinical Study to Assess the Equivalence of Tranexamic Acid vs Oxytocin in Reducing the PPH (TRANOXY2015)
• Postpartum Uterotonic Administration
• Topical Tranexamic Acid in Caesarean Section
• Comparative Study on the Effects of Sublingual Misoprostol in Addition to Standard AMTSL in Low Risk Parturients in LASUTH, Ikeja.
• Carbetocin Versus Ergometrine in the Management of Atonic Post Partum Haemorrhage (PPH) in Women Delivered Vaginally
• An Evidence Based Protocol for Oxytocin Administration in Vaginal Delivery
• Carbetocin Versus Oxytocin in Caesarean Section for the Control of Postpartum Haemorrhage
• Carbetocin and Oxytocin in Elective Caesarean Section With High Risk of Postpartum Hemorrhage
• Hexakaprone Treatment for Post-Partum Hemorrhage Prophylactic
• Investigating the Effect of Pulsatile Administration of Oxytocin on the Desensitization of Human Myometrium In-vitro
• Management of the Third Stage of Labor
• Ergometrine Versus Oxytocin in the Management of Atonic Post-partum Haemorrhage (PPH) in Women Delivered Vaginally
• Carbetocin Versus Oxytocin in the Management of Atonic Post Partum Haemorrhage (PPH) in Women Delivered Vaginally: A Randomised Controlled Trial
• Carbetocin Versus Oxytocin in the Prevention of Post Partum Haemorrhage (PPH) in Women Delivered Vaginally With at Least 2 Risk Factors for Atonic PPH: A Randomised Controlled Trial
• Carbetocin Versus Oxytocin in the Prevention of Post Partum Haemorrhage (PPH) in Women Undergoing Caesarean Sections for Placenta Previa: A Randomised Controlled Trial
• Tranexamic Acid for Preventing Postpartum Haemorrhage Following a Vaginal Delivery
• Carbetocin Versus Misoprostol in High Risk Patients for Postpartum Hemorrhage After C.S.
• Carbetocin Versus Misoprostol in Cases With Placenta Previa After C.S.
• Investigating the Effect of Extracellular Calcium on Oxytocin-induced Human Myometrial Contractility In-vitro
• Carbetocin at Elective Cesarean Delivery Part 4
• Comparison of Primary and Secondary Prevention of Postpartum Hemorrhage at the Community Level in Egypt
• Postpartum Hemorrhage Prevention in Patients With Preeclampsia (PHP3 Study)
• Intramuscular Oxytocics: A Randomised Control Trial
• Timing of Umbilical Cord Occlusion in Premature Babies( <33 w). Delayed vs Early.
• Treatment of Postpartum Hemorrhage With Misoprostol: Fever Study
• Fibrinogen in Haemorrhage of Delivery
• Carbetocin Versus Oxytocin and Ergometrine for the Prevention of Postpartum Haemorrhage Following Caesarean Section
• Prevention of Postpartum Hemorrhage in Patients With Severe Preeclampsia Using Carbetocin Versus Misoprostol
• Comparison Between Rectal & Sublingual Misoprostol Before Caesarian Section To Reduce Intra & Post-Operative Blood Loss
• Intramuscular Versus Intravenous Prophylactic Oxytocin for Hemorrhage After Vaginal Delivery
• Efficacy of Oxytocin vs. Carbetocin in Prevention of Postpartum Hemorrhage After Cesarean Section
• The Use of Oxytocin, Carbetocin and Buccal Misoprostol in Patients Undergoing Elective Cesarean Section (CS)
• Recovery of Oxytocin Responsiveness in Pregnant Human Myometrial Explants After Oxytocin-Induced Desensitization
• A Randomized Trial Comparing Oxytocin and Oxytocin + Ergometrine for Prevention of Postpartum Haemorrhage at Caesarean Section
• Carbetocin Versus Syntometrine for Prevention of Postpartum Hemorrhage After Cesarean Section
• Tranexamic Acid and Thromboelastography During Cesarean Delivery
• When and How to Administer Oxytocin for Active Management of Third Stage of Labour
• Oxytocin Infusions and Blood Loss in Patients Undergoing Elective Cesarean Delivery.
• The Effect of Rectal and Sublingual Misoprostol Administration in Postpartum or Intrapartum Haemorrhage at Elective Caesarean Delivery: a Randomized Controlled Trial
• Oxytocin Via Intramuscular Injection and Intravenous Bolus or Infusion for Prevention of Postpartum Hemorrhage
• PCC and Fibrinogen Compared With FFP in PPH
• Treatment of Women After Postpartum Haemorrhage
• Treatment of Women After Severe Postpartum Haemorrhage
• Comparison of IV Ergonovine With IM Carboprost, With Oxytocin IV, During Cesarean Section for Failure to Progress
• Combating Maternal Mortality in Uganda: An Assessment of the Role of Misoprostol in Prevention of Post-Partum Hemorrhage
• In-vitro Myometrial Contractility After Oxytocin Pre-exposure in Women With Advanced Maternal Age and Morbid Obesity
• Misoprostol Versus Oxytocin for Prevention of Post Partum Hemorrhage
• Buccal Misoprostol During Cesarean Section for Preventing Postpartum Hemorrhage
• Carbetocin at Cesarean Delivery for Labor Arrest
• Comparing Misoprostol and Oxytocin in Uniject for Postpartum Hemorrhage (PPH) Prevention in Senegal
• Misoprostol and Oxytocin in Uniject® for Postpartum Hemorrhage Prevention in Communities
• In Vitro Myometrial Contractions in Laboring and Non-laboring Women
• Carbetocin vs. Oxytocin: In-vitro Myometrial Contractions With and Without Oxytocin Pre-treatment
• Carbetocin at Elective Cesarean Delivery Part 3
• Comparison of Two Doses of Carbetocin for Prevention of Uterine Atony, During Elective Cesarean Section
• IV vs IM Oxytocin in the Third Stage of Labor for Prevention of Postpartum Hemorrhage
• Oxytocin, Carbetocin and Misopristol for Treatment of Postpartum Hemorrhage: A Multicentric Randomized Trial
• Can Tranexamic Acid Reduce Bleeding After Post Partum Hemorrhage in Cesarean Section Delivery
• ED90 Determination of Carbetocin for the Prevention of Uterine Atony in Women Undergoing an Elective Cesarean Delivery
• Evaluation of Melatonin's Effect on Pain and Blood Loss After Cesarean Section
• Combined Use of Oxytocin and Misoprostol Versus Oxytocin Infusion and Misoprostol Alone to Reduce Blood Loss at Cesarean Section
• A Study of Self-administered Misoprostol to Prevent Bleeding After Childbirth in the Community (MamaMiso)
• Misoprostol for Treatment of Postpartum Haemorrhage (PPH) in Home Births
• Comparing Misoprostol and Oxytocin in UnijectTM for Postpartum Hemorrhage (PPH) Prevention in Mali
• Treatment of Postpartum Haemorrhage (PPH) Using Misoprostol in Home Births
• Misoprostol for Secondary Prevention of Postpartum Hemorrhage at the Community Level in India
• Carbetocin at Elective Cesarean Delivery Part 2
• Carbetocin vs. Oxytocin for Prevention of Postpartum Bleeding in Patients With Severe Preeclampsia
• Prevention of Postpartum Haemorrhage With Sublingual Misoprostol or Oxytocin
• Fibrinogen Concentrate as Initial Treatment for Postpartum Haemorrhage: A Randomised Clinically Controlled Trial
• Carbetocin at Elective Cesarean Delivery
• Does Intramyometrial Oxytocin Improve Outcome in Elective Cesarean Delivery?
• Oxytocin in Cesarean Delivery
• Postpartum Oxygen Inhalation for the Treatment of Postpartum Haemorrhage
• Intrarectal Misoprostol in Postpartum Haemorrhage
• Combined Use of Oxytocin and Misoprostol in the Prevention of Post Partum Haemorrhage
• The Effect of Tranexamic Acid on Postpartum Hemorrhage During and After Cesarean Delivery
• Fever After Misoprostol Administration for the Treatment of Primary Postpartum Hemorrhage
• Impact of Uterotonic Agents on Isolated Human Myometrium
• World Maternal Antifibrinolytic Trial
• Oxytocin Regimen to Prevent Atony and Postpartum Hemorrhage During Vaginal Delivery: 3-arm RCT
• Carbetocin Versus Syntometrine for the Third Stage of Labour
• Active Versus Expectant Management of the Third Stage of Labor
• rhuFVIIa in Post-partum Hemorrhage
• Does the Rapid Intravenous Administration of Oxytocin After Delivery of the Baby Decrease the Bleeding During Cesarean Section in Women at Risk of Bleeding During Cesarean Section?
• Misoprostol for Preventing Postpartum Hemorrhage
• Misoprostol for the Prevention of Postpartum Hemorrhage in Rural Pakistan
• Optimisation of the Management of Placental Delivery in Second Trimester Pregnancy Interruption
• Misoprostol in the Treatment of Postpartum Hemorrhage
• Misoprostol for the Treatment of Postpartum Hemorrhage
• Oral Misoprostol Versus Intravenous Oxytocin in Preventing Blood Loss After Non-scheduled Cesarean Section
• RCT of Misoprostol for Postpartum Hemorrhage in India